Clinical Trials Directory

Trials / Sponsors / Shanghai HEP Pharmaceutical Co., Ltd.

Shanghai HEP Pharmaceutical Co., Ltd.

Industry · 8 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingPhase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D
Hepatitis D, Chronic
Phase 32026-04-01
WithdrawnA Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin
Type 2 Diabetes Patients
Phase 1 / Phase 22025-12-01
Active Not RecruitingA Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D
Hepatitis D
Phase 22024-12-11
CompletedStudy of Hepalatide in Chronic Hepatitis D(CHD) Patients
Chronic Hepatitis D Infection
Phase 22023-10-07
CompletedA Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients
Chronic Hepatitis B
Phase 22022-08-23
CompletedA Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B
Hepatitis B, Chronic
Phase 22021-06-18
CompletedStudy of Hepalatide(L47) at Phase Ib in Healthy Volunteers
Hepatitis B， Chronic
Phase 12016-08-01
CompletedSafety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers
Hepatitis B， Chronic
Phase 12015-10-01